During the past decade, Usf Asthma Allergy and Immunology Cru conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Usf Asthma Allergy and Immunology Cru" are "ALLERGIC RHINITIS" (1 trials), "ASTHMA" (1 trials), "Asthma" (1 trials), "Atopic Asthma" (1 trials) and "Chronic Nasal Congestion" (1 trials). Many other conditions were trialed in "Usf Asthma Allergy and Immunology Cru" in a lesser frequency.

Most popular intervention types in "Usf Asthma Allergy and Immunology Cru" are "Dietary Supplement" (2 trials), "Other" (2 trials), "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "CURCUMIN" (1 trials), "Oxymetazoline Hydrochloride" (1 trials), "Placebo" (1 trials), "dust mite extract or placebo" (1 trials) and "no intervention other than stopping study" (1 trials). Other intervention names were less common.

The vast majority of trials in "Usf Asthma Allergy and Immunology Cru" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Usf Asthma Allergy and Immunology Cru". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Usf Asthma Allergy and Immunology Cru, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Usf Asthma Allergy and Immunology Cru, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".